Emerging technologies in therapeutic oligonucleotides

13 March 2018, Medimmune Ltd., Cambridge, CB21 6GH

MedImmune, AstraZeneca and GE Healthcare Life Sciences, in partnership with GSK, Roche, University of Oxford, BioMax and Academy of Pharmaceutical Sciences are pleased to invite you to their sixth oligonucleotide networking event.

The title of this year's event is "Emerging technologies in therapeutic oligonucleotides". The meeting is kindly being hosted by MedImmune at their facility in Cambridge and is free to attend.

The focus of the 2018 meeting will be more in the discovery phase, with four main themes being covered throughout the day:

• CRISPR technologies

• Large molecule oligonucleotides

• Drug delivery

• Analytical and regulatory case studies

The meeting aims to bring together the community of interested professionals and practitioners in industry and academia to network, discuss the latest developments in this field, explore knowledge transfer issues and share best practise.

Free to attend